| Company name | StemRIM Inc. |
|---|---|
| Established | October 30, 2006 |
| Chief Executives | Masatsune Okajima (President & CEO) |
| Number of Employees | 71 (as of January 31, 2024) |
| Capital | 207 million yen (as of January 31, 2024) |
| Web-Site | https://www.stemrim.com/ |
| Address | Saito Bio-Incubator 3F, 7-7-15 Saito-Asagi, Ibaraki City, Osaka, 567-0085 Japan |
| Board of Directors | Masatsune Okajima, President & CEO Kensuke Tomita, Chairman Katsuto Tamai, Director, CSO Noriko Sawai, External Director Tadahiro Nagai, External Director |
| Audit & Supervisory Board Members | Yoji Kudo, External Audit & Supervisory Board Member (full-time) Akihiro Mizukami, External Audit & Supervisory Board Member Yoichiro Shimada, External Audit & Supervisory Board Member |
| Borad of Executive Officer | Takehiko Yamazaki, Executive Officer, Head of Drug Discovery Dept./Research & Development Dept./Intellectual Property Dept. |
